Could stem cell vesicles help heal the brain after a stroke?

NCT ID NCT06612710

Recruiting now Disease control Sponsor: Wei Wang Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial is testing a new treatment called NouvSoma001 for people who have had an ischemic stroke within the past week. The treatment uses tiny particles from stem cells, given through an IV, to see if it is safe and might help the brain recover. About 69 participants will be randomly assigned to receive either the active therapy or a placebo, and researchers will monitor side effects and brain healing over several months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NouvSoma001 (extracellular vesicles from human induced neural stem cells)
What this could lead to: If it works, this could point toward a new treatment that helps the brain repair itself after a stroke, potentially reducing long-term disability.
What could go wrong: This is a very early Phase 1 trial with only 69 people, so it is primarily checking safety. The therapy may not improve outcomes, and there could be unknown side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE

Contacts and locations

Locations

Tongji Hospital affiliated to Tongji Medical College of Huazhong University ofScience and Technology
RECRUITING

Wuhan, Hubei, 430000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.